It is also not known to have specific acute kidney injury or electrolyte risk factors comparable to those of ACE inhibitors and angiotensin receptor blockers (ARBs) [18], and therefore, cases of significant hypotension notwithstanding, ordering decisions are more likely to be dictated by individual physician practice, rather than patient-specific factors. Here, ACE is linked to acute kidney injury.